Bruton’s Tyrosine Kinase inhibitors: two strategies showcased in SeeSAR

In this webinar we will show you two exciting applications using SeeSAR. Two strategies for novel inhibitors against Bruton’s Tyrosine Kinase, one by Takeda and one by Genentech. Both examples benefit from SeeSAR’s dead easy-to-use GUI, its ability to classify compounds with respect to their affinity and torsions, and its ADME property calculations. Truly a medicinal chemist’s dashboard, SeeSAR stands out as the easiest to use modeling tool around. This webinar will show you why and how.